Larry Blandford, PharmD

Pharma Insights
Value Transformation: Observations on the Second Annual Evaluation Report of the Oncology Care Model
03/13/2019
The Centers for Medicare & Medicaid Services (CMS) posted its second annual evaluation report of the Oncology Care Model (OCM) in December 2018, covering first performance period and model year results. This...
The Centers for Medicare & Medicaid Services (CMS) posted its second annual evaluation report of the Oncology Care Model (OCM) in December 2018, covering first performance period and model year results. This...
The...
03/13/2019
Journal of Clinical Pathways
Pharma Insights
When Medication Price Deflates Perception of Therapeutic Effect
04/11/2016
Manufacturers set prices for their products that best represent their value while providing the greatest financial return on investment. Thus, conventional wisdom would suggest that manufacturers set a higher price...
Manufacturers set prices for their products that best represent their value while providing the greatest financial return on investment. Thus, conventional wisdom would suggest that manufacturers set a higher price...
...
04/11/2016
Journal of Clinical Pathways
Special Article
The Solution to More Effective Diabetes Management: Better Products or Better Programs?
12/09/2016
Larry Blandford, PharmD, discusses the high costs of diabetes treatment and questions whether better products or better programs are the solution to more effective diabetes care.
Larry Blandford, PharmD, discusses the high costs of diabetes treatment and questions whether better products or better programs are the solution to more effective diabetes care.
Larry Blandford, PharmD,...
12/09/2016
Journal of Clinical Pathways
Pharma Insights
The Challenge With Today’s Value Assessments: Not Evolving With the Evidence
04/16/2019
The methodologies employed within value assessments, especially by the Institute for Clinical and Economic Review (ICER), primarily measure value through quality-adjusted life-years (QALYs). While also the common...
The methodologies employed within value assessments, especially by the Institute for Clinical and Economic Review (ICER), primarily measure value through quality-adjusted life-years (QALYs). While also the common...
The...
04/16/2019
Journal of Clinical Pathways
Pharma Insights
Companion Diagnostics and Complementary Diagnostics in Clinical Practice: Better Medicine or Competitive Disadvantage?
05/06/2016
We are pleased to present the second installment in our recurring column, Pharma Insights. This month we take a look at an interesting twist in how the use of complementary and companion diagnostics is playing out in...
We are pleased to present the second installment in our recurring column, Pharma Insights. This month we take a look at an interesting twist in how the use of complementary and companion diagnostics is playing out in...
We are...
05/06/2016
Journal of Clinical Pathways
Pharma Insights
The Health Care Ecosystem and Social Determinants of Health: Surveys Suggest the Stage Is Set for Novel Collaborations
05/15/2019
Dr Hennessey relates her past personal experience with cancer care delivery when her mother was receiving chemotherapy for lung cancer, where an issue with care access could have significantly altered her mother’s...
Dr Hennessey relates her past personal experience with cancer care delivery when her mother was receiving chemotherapy for lung cancer, where an issue with care access could have significantly altered her mother’s...
Dr...
05/15/2019
Journal of Clinical Pathways
Pharma Insights
Could the Lack of an Efficient and Affordable Diagnostic Pathway Limit Market Access for New Alzheimer`s Treatments?
06/20/2016
The promise in the coming years of a novel therapeutic to slow the progression of the debilitating effects of Alzheimer’s disease (AD) is exciting and represents a monumental step forward in treating patients with...
The promise in the coming years of a novel therapeutic to slow the progression of the debilitating effects of Alzheimer’s disease (AD) is exciting and represents a monumental step forward in treating patients with...
The...
06/20/2016
Journal of Clinical Pathways
Pharma Insights
Evolution of Hub Services
06/18/2019
What began as patient call centers for select complex medicines has expanded to a full suite of support services, ranging from financial assistance to patient education: so-called hub services have become ubiquitous...
What began as patient call centers for select complex medicines has expanded to a full suite of support services, ranging from financial assistance to patient education: so-called hub services have become ubiquitous...
What...
06/18/2019
Journal of Clinical Pathways
Pharma Insights
Formulary Exclusion Lists Create Challenges for Pharma and Payers Alike
10/12/2016
The use of formulary exclusion lists is expanding—and such lists are beginning to shape the market by further limiting available drugs for narrow therapeutic areas while reducing redundancy of options in broader...
The use of formulary exclusion lists is expanding—and such lists are beginning to shape the market by further limiting available drugs for narrow therapeutic areas while reducing redundancy of options in broader...
The...
10/12/2016
Journal of Clinical Pathways
Pharma Insights
The Evolution of Value Frameworks and What Is Next
08/19/2019
Value assessment in oncology is an emerging area of interest. Multiple value frameworks have been launched in the past 5 years to help stakeholders analyze the cost-effectiveness, or affordability, of oncology...
Value assessment in oncology is an emerging area of interest. Multiple value frameworks have been launched in the past 5 years to help stakeholders analyze the cost-effectiveness, or affordability, of oncology...
Value...
08/19/2019
Journal of Clinical Pathways

Upcoming Events

February 2 ⁠–⁠ February 5
LLM Winter Symposium
February 7 ⁠–⁠ February 9
Western AF Symposium
February 27 ⁠–⁠ March 1
DCLF
March 17 ⁠–⁠ March 19
GD Solid Tumors
March 22 ⁠–⁠ March 23
NP Institute
March 27 ⁠–⁠ March 30
TCIV
March 31 ⁠–⁠ April 2
Rx summit logo
April 21 ⁠–⁠ April 24
Symposium on Advanced Wound Care
April 30 ⁠–⁠ May 4
WoundCon
May 1 ⁠–⁠ May 3
See Full Calendar

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use